These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25712181)

  • 1. Expansion of pharmacogenomics into the community pharmacy: billing considerations.
    O'Connor SK; Michaels N; Ferreri S
    Pharmacogenomics; 2015; 16(3):175-80. PubMed ID: 25712181
    [No Abstract]   [Full Text] [Related]  

  • 2. Making pharmacogenetic testing a reality in a community pharmacy.
    O'Connor SK; Ferreri SP; Michaels NM; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer M
    J Am Pharm Assoc (2003); 2012; 52(6):e259-65. PubMed ID: 23229988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a pharmacogenomics service in a community pharmacy.
    Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
    J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On pharmacogenomics in pharmacy benefit management.
    Russell Teagarden J; Stanek EJ
    Pharmacotherapy; 2012 Feb; 32(2):103-11. PubMed ID: 22392418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provider-administered drugs move to specialty pharmacy benefit.
    Manag Care; 2014 Apr; 23(4):49. PubMed ID: 24864535
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implications.
    Garrison LP; Carlson RJ; Carlson JJ; Kuszler PC; Meckley LM; Veenstra DL
    Drug Metab Rev; 2008; 40(2):377-401. PubMed ID: 18464050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APhA2008 House of Delegates: Advancing current practice, preserving pharmacy integrity for the future.
    Marciniak MW; Ried LD; Lipowski EE; Skelton Duke MV
    J Am Pharm Assoc (2003); 2008; 48(4):447-8, 451-4. PubMed ID: 18653416
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reforming Pharmacy Benefit Managers - A Review of Bipartisan Legislation.
    Cai C; Rome BN
    N Engl J Med; 2023 Nov; 389(18):1640-1643. PubMed ID: 37902281
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetics and ethical considerations: why care?
    Marx-Stölting L
    Pharmacogenomics J; 2007 Oct; 7(5):293-6. PubMed ID: 17033614
    [No Abstract]   [Full Text] [Related]  

  • 11. Capitation reimbursement for pharmacy services: a dissenting view.
    Gosselin RA
    Med Mark Media; 1980 Oct; 15(10):51-6. PubMed ID: 10249122
    [No Abstract]   [Full Text] [Related]  

  • 12. To Reform Pharmacy Reimbursement Begin with the Basics.
    Rupp MT
    J Manag Care Spec Pharm; 2020 Jun; 26(6):713-715. PubMed ID: 32463772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding a liability-free space in which personalized medicine can bloom.
    Evans BJ
    Clin Pharmacol Ther; 2007 Oct; 82(4):461-5. PubMed ID: 17713468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics: bridging the gap between science and practice.
    Lee KC; Ma JD; Kuo GM
    J Am Pharm Assoc (2003); 2010; 50(1):e1-14; quiz e15-7. PubMed ID: 20368146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State insurance commissioners weigh PBM regulations this month.
    Carlson B
    Manag Care; 2000 Mar; 9(3):19-20. PubMed ID: 11066209
    [No Abstract]   [Full Text] [Related]  

  • 16. Growing pains. Insurers and PbMs want in on 340B savings.
    Lee J
    Mod Healthc; 2012 Mar; 42(11):10. PubMed ID: 22462315
    [No Abstract]   [Full Text] [Related]  

  • 17. Is Rx couponing a viable direct-marketing technique?
    Spaulding CD; Josephs JW
    Am Pharm; 1992 Jan; NS32(1):67-71. PubMed ID: 1570791
    [No Abstract]   [Full Text] [Related]  

  • 18. Policing the "wild west" world of Internet pharmacies.
    Rost KT
    Spec Law Dig Health Care Law; 2002 Jan; (273):9-29. PubMed ID: 11881538
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retail pharmacy market structure and performance.
    Brooks JM; Doucette WR; Wan S; Klepser DG
    Inquiry; 2008; 45(1):75-88. PubMed ID: 18524293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.